Genentech - PDFSEARCH.IO - Document Search Engine

Genentech
Results: 384

#	Item
131	Chicago Disclosures for Microsite.xlsx Add to Reading List Source URL: boa.asco.org Language: English - Date: 2014-07-24 17:02:55 Celgene Pharmaceutical industry in India Pharmaceutical industry Technology Health Protein kinase inhibitor Genentech South San Francisco California Bristol-Myers Squibb
132	RAPTIVA® [efalizumab] For injection, subcutaneous WARNING: RISK OF PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY (PML) • RAPTIVA increases the risk for PML, a rapidly progressive viral infection of Add to Reading List Source URL: www.accessdata.fda.gov Language: English - Date: 2009-03-31 14:51:38 Efalizumab Progressive multifocal leukoencephalopathy JC virus Psoriasis Genentech Placebo Sepsis Medicine Health Immunosuppressants
133	sBLA[removed]Pertuzumab (Perjeta ®) Neoadjuvant Breast Cancer Application Genentech, Inc. FDA Introductory Remarks Add to Reading List Source URL: www.fda.gov Language: English Neoadjuvant therapy Trastuzumab Breast cancer Oncology MammaPrint Adjuvant therapy Medicine Cancer treatments Ribbon symbolism
134	DEPARTMENT OF HEALTH & HUMAN Add to Reading List Source URL: www.fda.gov Language: English Health Biotechnology Biologic License Application Center for Biologics Evaluation and Research Biologic Genentech Adverse effect Pharmacology Medicine Food and Drug Administration
135	Herceptin (Trastuzumab) Label Add to Reading List Source URL: www.fda.gov Language: English Tyrosine kinase receptors Cancer treatments Trastuzumab Ribbon symbolism HER2/neu Anatomical pathology Breast cancer Genentech Metastatic breast cancer Medicine Biology Oncology
136	PDF Document Add to Reading List Source URL: www.fda.gov Language: English Tyrosine kinase receptors Cancer treatments Trastuzumab Ribbon symbolism HER2/neu Genentech Breast cancer Metastatic breast cancer ErbB Medicine Oncology Biology
137	Summary of Research & Developments, June 2011 Through May 2012 IMDSG Presentation Dan Roberts June 2012 Introduction Here is MD Support’s summary of the past twelve months of significant research and Add to Reading List Source URL: www.mdsupport.org Language: English - Date: 2014-04-27 21:05:22 Angiology Bevacizumab Macular degeneration Ranibizumab Vascular endothelial growth factor Choroidal neovascularization Genentech Presumed ocular histoplasmosis syndrome Age-Related Eye Disease Study Medicine Health Ophthalmology
138	Dermatologic and Ophthalmic Drugs Advisory Committee Meeting BLA[removed]for Lucentis (ranibizumab injection) Rhea A. Lloyd, M.D. US Food and Drug Administration Add to Reading List Source URL: www.fda.gov Language: English Ranibizumab Vascular endothelial growth factor Diabetes Macular degeneration Macular edema Diabetic retinopathy Genentech Ketorolac Off-label use Medicine Ophthalmology Health
139	sBLA[removed]Pertuzumab (Perjeta) ODAC Briefing Document FDA Briefing Document Add to Reading List Source URL: www.fda.gov Language: English Biology Trastuzumab Cancer treatments Breast cancer treatment Breast cancer Docetaxel Pertuzumab Adjuvant therapy Genentech Medicine Ribbon symbolism Oncology
140	M.L. Springer p. 1 University of California, San Francisco CURRICULUM VITAE Add to Reading List Source URL: cardiolab.ucsf.edu Language: English - Date: 2014-11-28 15:27:33 University of California San Francisco Genentech Geography of California

UPDATE